MX2023003089A - Formas farmaceuticas solidas de bacterias. - Google Patents

Formas farmaceuticas solidas de bacterias.

Info

Publication number
MX2023003089A
MX2023003089A MX2023003089A MX2023003089A MX2023003089A MX 2023003089 A MX2023003089 A MX 2023003089A MX 2023003089 A MX2023003089 A MX 2023003089A MX 2023003089 A MX2023003089 A MX 2023003089A MX 2023003089 A MX2023003089 A MX 2023003089A
Authority
MX
Mexico
Prior art keywords
bacteria
dosage forms
solid dosage
agents
facilitate
Prior art date
Application number
MX2023003089A
Other languages
English (en)
Inventor
Chun Zhang
Syed Altaf
Ruiming Huang
Robert Ward
Ryan Wilson
Original Assignee
Evelo Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evelo Biosciences Inc filed Critical Evelo Biosciences Inc
Publication of MX2023003089A publication Critical patent/MX2023003089A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

En el presente documento se proporcionan métodos y composiciones relacionados con formas farmacéuticas sólidas que facilitan el suministro de bacterias y/o agentes de origen bacteriano por vía oral.
MX2023003089A 2020-09-18 2021-09-17 Formas farmaceuticas solidas de bacterias. MX2023003089A (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US202063080263P 2020-09-18 2020-09-18
US202063089799P 2020-10-09 2020-10-09
US202063110090P 2020-11-05 2020-11-05
US202163145786P 2021-02-04 2021-02-04
US202163157153P 2021-03-05 2021-03-05
US202163161617P 2021-03-16 2021-03-16
US202163234483P 2021-08-18 2021-08-18
PCT/US2021/050844 WO2022061094A1 (en) 2020-09-18 2021-09-17 Solid dosage forms of bacteria

Publications (1)

Publication Number Publication Date
MX2023003089A true MX2023003089A (es) 2023-05-09

Family

ID=78402212

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023003089A MX2023003089A (es) 2020-09-18 2021-09-17 Formas farmaceuticas solidas de bacterias.

Country Status (10)

Country Link
US (1) US20230372409A1 (es)
EP (1) EP4213814A1 (es)
JP (1) JP2023543416A (es)
KR (1) KR20230088724A (es)
AU (1) AU2021342481A1 (es)
CA (1) CA3192766A1 (es)
CO (1) CO2023004540A2 (es)
MX (1) MX2023003089A (es)
TW (1) TW202228653A (es)
WO (1) WO2022061094A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023177875A1 (en) 2022-03-17 2023-09-21 Evelo Biosciences, Inc. Methods and compositions for anaerobic contaminant testing
WO2023239728A1 (en) 2022-06-07 2023-12-14 Evelo Biosciences, Inc. Compositions and methods of treating inflammation using prevotella histicola extracellular vesicles
WO2024028479A1 (en) * 2022-08-05 2024-02-08 Universite Catholique De Louvain Dysosmobacter for the treatment of breast cancer

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775536A (en) 1986-02-24 1988-10-04 Bristol-Myers Company Enteric coated tablet and process for making
US5292522A (en) 1989-06-20 1994-03-08 Rohm Gmbh Aqueous film coating agent for solid medicaments
US5047258A (en) 1989-07-14 1991-09-10 Sterling Drug Inc. Aqueous spray-coating process
US6623759B2 (en) 1996-06-28 2003-09-23 Astrazeneca Ab Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
DE19631084A1 (de) 1996-08-01 1998-02-05 Basf Ag Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut
US6312728B1 (en) 1998-07-07 2001-11-06 Cascade Development, Inc. Sustained release pharmaceutical preparation
EP1101490B1 (en) 1998-07-28 2005-04-13 Tanabe Seiyaku Co., Ltd. Preparation capable of releasing drug at target site in intestine
US20040028737A1 (en) 2002-08-12 2004-02-12 Kopran Research Laboratories Limited Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same
DE10260919A1 (de) 2002-12-20 2004-07-01 Röhm GmbH & Co. KG Verfahren zur Herstellung von überzogenen Arzneiformen und Nahrungsergänzungsmitteln mit Konzentrationsgradienten im Überzug
WO2005044240A2 (en) 2003-10-31 2005-05-19 Dexcel, Ltd. Stable lansoprazole formulation
US9149439B2 (en) 2005-03-21 2015-10-06 Sandoz Ag Multi-particulate, modified-release composition
DE102005032806A1 (de) 2005-07-12 2007-01-18 Röhm Gmbh Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten
EP2648528B1 (en) * 2010-12-06 2016-07-20 Degama Berrier Ltd. Composition and method for improving stability and extending shelf life of probiotic bacteria and food products thereof
RU2015141706A (ru) 2013-03-01 2017-04-06 БиПиЭсАй ХОЛДИНГЗ, ЭлЭлСи. Пленочные покрытия с отсроченным высвобождением, содержащие силикат кальция, и субстраты, покрытые ими
DK3600364T3 (da) 2017-06-14 2020-08-31 4D Pharma Res Ltd Sammensætninger omfattende en bakteriestamme af slægten megasphaera og anvendelser deraf
KR20200053532A (ko) * 2017-09-08 2020-05-18 에벨로 바이오사이언시즈, 인크. 프레보텔라로부터의 세포외 소포
CN111148531A (zh) * 2017-09-08 2020-05-12 伊夫罗生物科学公司 细菌胞外囊泡
TW202038979A (zh) 2018-12-12 2020-11-01 英商4D製藥研究有限公司 包含細菌菌株之組成物

Also Published As

Publication number Publication date
AU2021342481A1 (en) 2023-05-04
EP4213814A1 (en) 2023-07-26
US20230372409A1 (en) 2023-11-23
KR20230088724A (ko) 2023-06-20
CA3192766A1 (en) 2022-03-24
WO2022061094A1 (en) 2022-03-24
TW202228653A (zh) 2022-08-01
JP2023543416A (ja) 2023-10-16
CO2023004540A2 (es) 2023-07-10

Similar Documents

Publication Publication Date Title
MX2023003089A (es) Formas farmaceuticas solidas de bacterias.
MX2021015427A (es) Vesiculas extracelulares microbianas procesadas.
MX2022002465A (es) Inhibidores de kras g12d.
CR20220070A (es) Inhibidores de parp1
PH12020551261A1 (en) Il-15 conjugates and uses thereof
MX2022015272A (es) Inhibidores de la proteina kras g12c y usos de estos.
MX2021010868A (es) Bacteria de la familia christensenellaceaeas en la prevencion y/o tratamiento de enfermedades inflamatorias cronicas y/o enfermedades gastrointestinales inflamatorias y/o canceres.
CR20220082A (es) N4-hidroxicitidina y derivados y usos antivirales relacionados con los mismos
MY155299A (en) Oral dosage composition
MX2020006191A (es) Bacteriocinas terapeuticas.
PH12021550611A1 (en) Interleukin 10 Conjugates and Uses Thereof
MX2022014007A (es) Compuestos como inhibidores de bcl-2.
BR112018014464A2 (pt) probióticos para alterar a composição de biofilmes orais
MX2020009733A (es) Composiciones.
WO2019178487A3 (en) Compositions and methods for treating disease using klebsiella quasipneumoniae subsp. similipneumoniae
WO2017024059A8 (en) Ionizing irradiation sterilization of bacterial minicell-based biopharmaceuticals and methods of use
MX2023002233A (es) Compuestos fosfolipidos y usos de estos.
MX2023003678A (es) Inhibidores de hidroxiesteroide 17beta- deshidrogenasa 13 (hsd17b13) y usos de estos.
MX2023003677A (es) Inhibidores de hidroxiesteroide 17beta- deshidrogenasa 13 (hsd17b13) y usos de estos.
ZA202102702B (en) Synergistic disinfectant compositions having enhanced antimicrobial efficacy and stability, and methods of using the same
WO2021004958A3 (en) Compositions comprising bacterial strains
MX2022006109A (es) Derivados 1-aminosulfonil-2-carboxipirrol como inhibidores de metalo-beta-lactamasa.
MX2022000712A (es) Moduladores de nlrp3.
MX2022001973A (es) Formulaciones para la prevención o reducción de infecciones por c. difficile.
MX2022001428A (es) Metodos y composiciones para cultivar bacterias dependientes de hemoglobina.